Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

H&F, Bain Capital tap into health tech boom with $17 billion Athenahealth deal

Published 11/22/2021, 09:19 AM
Updated 11/22/2021, 12:37 PM
© Reuters. FILE PHOTO: The logo of Bain Capital is displayed on the screen during a news conference in Tokyo, Japan October 5, 2017. REUTERS/Kim Kyung-Hoon

(Reuters) -Private-equity firms Hellman & Friedman LLC and Bain Capital on Monday agreed to buy Athenahealth for $17 billion, the latest sign of rising interest in companies powering the healthcare sector's shift to the cloud.

Privately held Athenahealth offers software that can help organize patient visits, document patient records and simplify payments. It competes with the likes of Cerner Corp (NASDAQ:CERN).

Companies providing cloud-based solutions to the healthcare sector have enjoyed a demand surge during the COVID-19 pandemic as home-bound people turn to the web for their medical needs.

The boom has sparked several deals in the sector, including Microsoft Corp (NASDAQ:MSFT)'s $16 billion buyout of Nuance Communications (NASDAQ:NUAN) Inc in April.

The healthcare industry has also seen a rise in dealmaking by private-equity firms, which have joined hands this year to acquire companies for huge sums.

Blackstone (NYSE:BX), Carlyle Group (NASDAQ:CG) and Hellman & Friedman together agreed to buy medical supply and equipment company Medline Industries Inc in June for $34 billion, including debt. nL4N2M536I]

Athenahealth was taken private in 2019 by Evergreen Coast Capital, hedge fund Elliott's private equity arm, and investment firm Veritas in a $5.7 billion deal.

It later merged with Virence Health, a healthcare software provider Veritas bought from General Electric (NYSE:GE) Co.

"Following our take-private and combination with Virence in 2019, Athenahealth delivered unrivaled value to its customers by significantly increasing R&D investment," said Ramzi Musallam, CEO of Veritas Capital.

Veritas and Evergreen will retain a minority stake in Athenahealth, which will also be partially owned by other investors such as Singapore sovereign wealth fund GIC.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The deal is expected to close in the first quarter of 2022 and Bob Segert will continue as the top boss of Athenahealth.

Evercore and Goldman Sachs & Co (NYSE:GS) were the lead financial advisors to Athenahealth and Veritas Capital.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.